Idiopathic Bilateral HIV-Associated Osteonecrosis of Femoral Heads

Authors

  • Dr Zairul Nizam Fithri International Medical University
  • Tharshini Muniandy International Medical University

DOI:

https://doi.org/10.31282/joti.v7n3.134

Keywords:

Idiopathic osteonecrosis, HIV infection, femoral heads

Abstract

Background: Avascular necrosis (osteonecrosis) is an increasingly recognized complication in patients living with HIV, particularly when weight-bearing joints such as the hip are involved. Although previously attributed primarily to antiretroviral therapy, HIV infection itself may be an independent risk factor.

Case Report: A 33-year-old woman with HIV infection diagnosed three years earlier presented with an eight-month history of progressively worsening bilateral hip pain, eventually resulting in an inability to ambulate without assistance. Clinical examination was suggestive of avascular necrosis, which was confirmed by bilateral hip radiographs and magnetic resonance imaging, demonstrating Steinberg Stage IV disease. There was no history of other recognized causes of osteonecrosis. She was compliant with highly active antiretroviral therapy (HAART) consisting of tenofovir, emtricitabine, and efavirenz. The advanced disease at presentation suggests that osteonecrosis may have developed substantially earlier than expected in the course of her HIV infection.

Conclusion: Although HAART may be associated with avascular necrosis, HIV infection itself may represent an independent risk factor. This case highlights that severe osteonecrosis may develop early in the course of HIV infection, emphasizing the importance of early recognition of musculoskeletal symptoms in these patients.

Downloads

Download data is not yet available.

References

1. Moya-Angeler J, Gianakos AL, Villa JC, Ni A, Lane JM. Current concepts on osteonecrosis of the femoral head. Vol. 6, World Journal of Orthopedics. Baishideng Publishing Group Co; 2015. p. 590–601

2. Petek D, Hannouche D, Suva D. Osteonecrosis of the femoral head: Pathophysiology and current concepts of treatment. EFORT Open Rev. 2019 Mar 1;4(3):85–97.

3. Morse CG, Mican JAM, Jones EC, Joe GO, Rick ME, Formentini E, et al. The incidence and natural history of osteonecrosis in HIV-infected adults. Clinical Infectious Diseases. 2007 Mar 1;44(5):739–48

4. Borges ÁH, Hoy J, Florence E, Sedlacek D, Stellbrink HJ, Uzdaviniene V, et al. Antiretrovirals, Fractures, and Osteonecrosis in a Large International HIV Cohort. Clinical Infectious Diseases. 2017 May 15;64(10):1413–21.

5. Permpalung N, Ungprasert P, Summachiwakij S, Leeaphorn N, Knight EL. Protease inhibitors and avascular necrosis: A systematic review and meta-analysis. Vol. 44, International Journal of Antimicrobial Agents. Elsevier B.V.; 2014. p. 93–5.

6. Mehta P, Nelson M, Brand A, Boag F. Avascular necrosis in HIV. Vol. 33, Rheumatology International. 2013. p. 235–8.

7. Matos MA, Watt De Alencar R, Souza S, Matos R. Avascular Necrosis of the Femoral Head in HIV Infected Patients [Internet]. Vol. 11, The Brazilian Journal of Infectious Diseases. 2007. Available from: www.bjid.com.br

8. Steinberg ME, Hayken GD, Steinberg DS. A quantitative system for staging avascular necrosis. Journal of Bone and Joint Surgery - Series B. 1995;77(1):34–41.

9. Whitlock GG, Herbert S, Copas A, Gilson R, Ainsworth JG. Avascular necrosis in HIV patients: A case-control study. Int J STD AIDS. 2013 Jul;24(10):799–803.

10. Lawson-Ayayi S, Bonnet F, Bernardin E, Ragnaud JM, Lacoste D, Malvy D, et al. Avascular Necrosis in HIV-Infected Patients: A Case-Control Study from the Aquitaine Cohort. Vol. 40, Clinical Infectious Diseases. 2004.

11. Green KR, Hernandez-Jimenez JM, Isache CL, Jacob R. Avascular necrosis: A growing concern for the HIV population. BMJ Case Rep. 2018;2018.

12. Bayard C, Ledergerber B, Flepp M, Lecompte T, Moulin E, Hoffmann M, et al. Associations between antiretroviral treatment and avascular bone necrosis: The swiss HIV cohort study. Open Forum Infect Dis. 2017 Oct 1;4(4).

13. European AIDS Clinical Society (EACS) Guidelines Version 11.1 2021

14. WHO Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Recommendations for a public health approach. 2nd Ed 2016.

15. World Health Organization. WHO Fact sheets on antiretroviral drugs. New Delhi 2002.

Additional Files

Published

2026-10-30